China shares snap rally as experimental vaccines stoke safety concerns
The smaller Shenzhen index ended down 0.91% and the start-up board ChiNext Composite index was weaker by 1.555%.

Healthcare and consumer shares fell, with the consumer staples sector losing 1.81% and the healthcare sub-index down 1.83%. Shanghai Fosun Pharmaceutical Group Co dropped 5% to the lowest in nearly two months, while index heavyweight Kweichow Moutai shed 1.9%. The smaller Shenzhen index ended down 0.91% and the start-up board ChiNext Composite index was weaker by 1.555%. China is inoculating tens of thousands of its citizens with experimental vaccines. Aiming to reduce the likelihood of a resurgence, the vaccines are also grabbing attention in the global scramble by governments to secure supplies, potentially helping reframe China's perceived role in the pandemic.
Bucking the trend, shares of auto-related firms rose with BYD Co, which manufactures electric buses that are sold in the United States, hitting a record high in Shenzhen on robust foreign inflows via the Stock Connect. Fuyao Glass Industry Group Co, which also runs a factory in the United States, ended at an all-time high. The World Trade Organization found on Tuesday that the United States had breached global trading rules by imposing multi-billion dollar tariffs in President Donald Trump's trade war with China, a ruling that drew anger from Washington.
Shares of Zhejiang Dahua Technology Co closed 6.4% lower after rising up to 4% earlier in the session. Alibaba Group Holding Ltd and China Mobile Communications Group Co are considering investing $443 mln in Dahua, three people with knowledge of the matter said. Around the region, MSCI's Asia ex-Japan stock index was firmer by 0.65%, while Japan's Nikkei index closed up 0.09%. At 0702 GMT, the yuan was quoted at 6.7704 per U.S. dollar, 0.17% firmer than the previous close of 6.7818.
Download ET Markets APP